BioSpace News Archive

WOBURN, Mass., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN today announced that Sherri M. Brown, Ph.D. was appointed to the Company’s Board of Directors effective February 11, 2020. In connection with her appointment, Dr. Brown will serve as chair of a newly formed Science and Technology Committee of the Board. Dr. Brown previously served as a Special Commercial and Technical Advisor to the Company. “We are delighted that Sherri is expanding her role with Yield10

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the results of the study, “Prone single-position extreme lateral interbody fusion (pro-XLIF): preliminary results,

Precision gene-edited traits for one of the world’s largest crops to help reduce farmers’ costs, while improving yield and quality

Persivia, a provider of real-time bundled payment, value based care, population health, and quality management solutions, announced today that its client Prime Healthcare has achieved significant savings under performance year one of BPCI Advanced.

Targeted colonic delivery shown Drug well-tolerated WAKEFIELD, Mass., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, is pleased to announce that preliminary top-line data from its Phase 1 trial ( NCT03234465 ) studying the use of delayed-release tablets of Brilacidin showed the trial met its primary endpoints. In the study, the timed-release OralogiK™ formulation of Brilacidin was radiolabeled (with

Cyclic dinucleotides are the most abundant second messengers in bacteria, modulating a variety of cellular activities in prokaryotic cells.

SwirlNet™ Therapeutic Device and eSuction™ Distal Cap Aid Physicians in Foreign Body Retrieval, Including Food Bolus Impactions [13-February-2020] CENTER VALLEY, Pa. , Feb. 13, 2020 /PRNewswire/ -- Olympus, a global technology leader in designing and delivering innovative solutions for endoscopic and surgical procedures, among other core businesses, announced today an

Ivy Rehab Physical Therapy, a national leader in outpatient musculoskeletal rehabilitative services, is proud to announce that All-Care Physical Therapy has joined its network of physical and occupational therapy practices.

Feb. 13, 2020 15:00 UTC BEIJING--( BUSINESS WIRE )-- Genetron Holdings Limited (“Genetron Health”), a China-based precision oncology company that covers full-cycle cancer care, announced that the National Medical Products Administration (NMPA) has approved its 8-gene Lung Cancer Assay and high-throughput NGS platform GENETRON S2000 to empower comprehensive panel genomic testing for more patients. The 8-gene Lung Cancer Assay is the first lung cancer clinical testing assay bas

Agreement secures a 2D patented printing technology that will significantly boost production capacity and reduce production costs Further protects CAUMZ™ and HCC011 with four additional manufacturing patents OTTAWA, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Tetra Bio Pharma Inc. (“ Tetra ” or the “ Company ”) (TSX-V:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, today announced it has signed a definitive manufacturing agreement with Vitiprints LLC, for the